Sponsors
Silver Sponsors
San Francisco, California-based Napo Pharmaceuticals, a Jaguar Health family company, focuses on developing innovative, patient-centric therapeutic solutions for essential supportive care and the management of neglected side eects across complicated disease states. Our goal is to redene what is possible in supportive care, providing hope and improving outcomes for patients worldwide. For more information visit: https://napopharma.com/
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Fresenius Kabi, A Company Built on a Promise For us, care is a fundamental obligation, mission, and daily source of inspiration. It is the momentum that pushes us forward to help elevate the quality of life for both caregivers and those who need it most: critically and chronically ill patients. By providing essential medicines and technologies for infusion, transfusion, and medical nutrition, we are helping advance the future of healthcare, making it even more accessible, reliable, and in tune with current and future needs.
Our Purpose at Sandoz is clear: pioneering access for patients We focus on driving access to make a difference for patients and are already doing so in a very real way. How? We specialize in the development of generic and biosimilar medicines. That means we develop more affordable versions of high-quality medicines once their key patents have expired. For us, pioneering access for patients means going new ways in how we develop new products in line with patient needs, how we produce cutting-edge medicines at prices people can afford, and how we get the medicines to the patients who need them. As the leading supplier of such medicines – which account for around 80% of medicines worldwide – we make access to high-quality medicines more affordable. Why? Because medicines can only transform lives when they reach those who need them. While they can be powerful, originator medicines are often too expensive for many healthcare systems and patients. Developing off-patent medicines makes them more affordable and accessible. Going forward, we expect to make an even bigger difference to those who need affordable, sustainable and high-quality healthcare.